Home Cart 0 Sign in  
X

[ CAS No. 1671-87-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1671-87-0
Chemical Structure| 1671-87-0
Chemical Structure| 1671-87-0
Structure of 1671-87-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1671-87-0 ]

Related Doc. of [ 1671-87-0 ]

Alternatived Products of [ 1671-87-0 ]

Product Details of [ 1671-87-0 ]

CAS No. :1671-87-0 MDL No. :MFCD00121717
Formula : C12H8N6 Boiling Point : -
Linear Structure Formula :- InChI Key :JFBIRMIEJBPDTQ-UHFFFAOYSA-N
M.W : 236.23 Pubchem ID :315109
Synonyms :

Calculated chemistry of [ 1671-87-0 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 6.0
Num. H-bond donors : 0.0
Molar Refractivity : 64.08
TPSA : 77.34 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -7.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.24
Log Po/w (XLOGP3) : -0.14
Log Po/w (WLOGP) : 1.39
Log Po/w (MLOGP) : 0.85
Log Po/w (SILICOS-IT) : 1.84
Consensus Log Po/w : 1.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.82
Solubility : 3.54 mg/ml ; 0.015 mol/l
Class : Very soluble
Log S (Ali) : -1.03
Solubility : 22.0 mg/ml ; 0.0933 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -5.2
Solubility : 0.00148 mg/ml ; 0.00000625 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.27

Safety of [ 1671-87-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1671-87-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1671-87-0 ]
  • Downstream synthetic route of [ 1671-87-0 ]

[ 1671-87-0 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 19081-87-9 ]
  • [ 1671-87-0 ]
YieldReaction ConditionsOperation in experiment
85% With nitric acid; acetic acid In water at 0℃; 8.0 g (0.077 mole) of 2-cyanopyridine was dissolved in 200 ml of anhydrous ethanol, the solution was added into a three-neck flask, and 9.54 ml (0.308 mole) of 95percent hydrazine hydrate was then added thereto. The mixture was refluxed for 6 hours to obtain 7.54 g (81.7percent yield) of orange-colored dianhydride base. The base was filtered, washed several times with ethanol, dissolved in glacial acetic acid and cooled on an ice bath, and 5-6 ml of concentrated nitric acid was slowly added dropwise thereto. The mixture was poured over crushed ice, made basic with sodium bicarbonate and then extracted two times with chloroform. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure, thus obtaining 6.3 g (85percent yield) of 3,6-bis(2'-pyridyl)-l,2,4,5-tetrazine as a purple solid. 6.3 g (0.027 mole) of the obtained 3,6-bis(2'-pyridyl)-l,2,4,5-tetrazine was dissolved in dimethyl- formamide (hereinafter, referred to as DMF), and the solution was added into a three- neck flask and refluxed with bubbling of acetylene. As the reaction progressed, the mixture was changed from a purple color to a clear color. DMF was evaporated under reduced pressure, and the residue was extracted with ethyl acetate. The resulting solid material was purified by silica gel column chromatography using ethylacetate: n- hexane (1:4, v/v)
Reference: [1] Patent: WO2007/7943, 2007, A1, . Location in patent: Page/Page column 8
  • 2
  • [ 100-70-9 ]
  • [ 1671-87-0 ]
Reference: [1] European Journal of Organic Chemistry, 2008, # 12, p. 2156 - 2166
[2] Journal of Organic Chemistry, 2005, vol. 70, # 21, p. 8468 - 8471
[3] Chemical Communications, 2012, vol. 48, # 12, p. 1736 - 1738
[4] Angewandte Chemie - International Edition, 2013, vol. 52, # 52, p. 14112 - 14116[5] Angew. Chem., 2013, vol. 125, # 52, p. 14362 - 14366,5
[6] Organic and Biomolecular Chemistry, 2014, vol. 12, # 23, p. 3950 - 3955
[7] Patent: US2016/106859, 2016, A1,
  • 3
  • [ 1671-86-9 ]
  • [ 1671-87-0 ]
Reference: [1] Chemical Communications, 2012, vol. 48, # 12, p. 1736 - 1738
[2] Angewandte Chemie - International Edition, 2013, vol. 52, # 52, p. 14112 - 14116[3] Angew. Chem., 2013, vol. 125, # 52, p. 14362 - 14366,5
[4] Organic and Biomolecular Chemistry, 2014, vol. 12, # 23, p. 3950 - 3955
  • 4
  • [ 1671-86-9 ]
  • [ 1671-87-0 ]
Reference: [1] Patent: US2016/106859, 2016, A1, . Location in patent: Paragraph 0192; 0193
[2] Dalton Transactions, 2017, vol. 46, # 24, p. 7878 - 7887
  • 5
  • [ 100-70-9 ]
  • [ 75-05-8 ]
  • [ 57537-63-0 ]
  • [ 1671-87-0 ]
Reference: [1] Chemistry - A European Journal, 2016, vol. 22, # 39, p. 13985 - 13998
  • 6
  • [ 74222-83-6 ]
  • [ 65520-11-8 ]
  • [ 6830-78-0 ]
  • [ 1671-87-0 ]
  • [ 73720-51-1 ]
Reference: [1] Tetrahedron Letters, 1981, vol. 22, # 15, p. 1393 - 1396
  • 7
  • [ 1671-87-0 ]
  • [ 1676-81-9 ]
  • [ 36901-11-8 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 1, p. 243 - 247[2] Angew. Chem., 2017, vol. 129, # 1, p. 249 - 253,5
Same Skeleton Products
Historical Records